July 16, 2021 | National Law Journal
Adapting Remote Proceedings in the Post-Pandemic Era: TrialsBy providing practitioners and judges with clear and uniform guidance, and developing a set of shared expectations across the country, the federal court system could better incorporate virtual bench trials in a manner that captures efficiencies and limits unwanted transaction costs.
By Michelle M. Bufano, Joshua Kipnees and Ian C. Kerr
6 minute read
July 15, 2021 | National Law Journal
Adapting Remote Proceedings in the Post-Pandemic Era: DepositionsVirtual depositions are destined to remain a fixture in the post-COVID era, but must also be balanced against the return of in-person depositions.
By Michelle M. Bufano, Joshua Kipnees and Ian C. Kerr
5 minute read
July 14, 2021 | National Law Journal
Adapting to Remote Proceedings in the Post-Pandemic Era: Pre-Trial ProceedingsThere is little doubt that remote litigation alternatives are here to stay. But the precise contours of the new status quo remain unclear.
By Michelle M. Bufano, Joshua Kipnees and Ian C. Kerr
5 minute read
December 11, 2019 | New Jersey Law Journal
Assessing Potential Risk: Due Diligence for Acquisition of Product ManufacturersA look at the areas that should be explored when evaluating an acquisition or merger from the perspective of both a products liability lawyer and a corporate transactional attorney.
By Michelle M. Bufano and Peter J. Schaeffer
9 minute read
February 20, 2017 | New Jersey Law Journal
NJ Supreme Court Takes Us Back in Time on Tort Statute of LimitationsA recent New Jersey Supreme Court decision has changed the rules of the game with respect to statute of limitations and choice of law for tort actions.
By Michelle M. Bufano and Rachel B. Sherman
19 minute read
December 12, 2016 | New Jersey Law Journal
Recent 'Reglan' Decision Chips Away at PreemptionA recent New Jersey Supreme Court decision expanded consumers' ability to recover against a generic-drug manufacturer under a state law failure-to-warn claim.
By Michelle M. Bufano, Cassye M. Cole and Matthew Funk
16 minute read
December 09, 2015 | New Jersey Law Journal
Getting Serious About Senseless ClaimsUnsupported lawsuits have no place in the courts. Unfortunately, attorneys are often faced with junk claims against which they must defend.
By Michelle M. Bufano and Randy A. Gray
9 minute read
December 09, 2015 | New Jersey Law Journal
Getting Serious About Senseless ClaimsUnsupported lawsuits have no place in the courts. Unfortunately, attorneys are often faced with junk claims against which they must defend.
By Michelle M. Bufano and Randy A. Gray
9 minute read
December 14, 2012 | New Jersey Law Journal
New Limitations on The Discovery Rule in Products Liability CasesThe Supreme Court's recent decision in Cornett v. Johnson & Johnson, 211 N.J. 362 (2012), seemingly narrows the scope of the discovery rule by finding that the determinations of a Food and Drug Administration advisory committee, regarding a particular product, are sufficient to put a plaintiff on notice of the existence of a possible claim.
By Michelle M. Bufano and Evan S. Harris
8 minute read
December 07, 2011 | New Jersey Law Journal
Irreconcilable Differences in Prescription Drug Liability CasesLevine, Mensing and pre-emption of failure-to-warn claims brought under state law.
By Michelle M. Bufano and Stephen J. Finley Jr.
6 minute read